Literature DB >> 16020540

Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance.

Christine M Kitsos1, Uma Sankar, Maddalena Illario, Josep M Colomer-Font, Andrew W Duncan, Thomas J Ribar, Tannishtha Reya, Anthony R Means.   

Abstract

The hematopoietic stem cell (HSC) gives rise to all mature, terminally differentiated cells of the blood. Here we show that calmodulin-dependent protein kinase IV (CaMKIV) is present in c-Kit+ ScaI+ Lin(-/low) hematopoietic progenitor cells (KLS cells) and that its absence results in hematopoietic failure, characterized by a diminished KLS cell population and by an inability of these cells to reconstitute blood cells upon serial transplantation. KLS cell failure in the absence of CaMKIV is correlated with increased apoptosis and proliferation of these cells in vivo and in vitro. In turn, these cell biological defects are correlated with decreases in CREB-serine 133 phosphorylation as well as in CREB-binding protein (CBP) and Bcl-2 levels. Re-expression of CaMKIV in Camk4-/- KLS cells results in the rescue of the proliferation defects in vitro as well as in the restoration of CBP and Bcl-2 to wild type levels. These studies show that CaMKIV is a regulator of HSC homeostasis and suggest that its effects may be in part mediated via regulation of CBP and Bcl-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020540     DOI: 10.1074/jbc.M505208200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Gfer is a critical regulator of HSC proliferation.

Authors:  Uma Sankar; Anthony R Means
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 2.  Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.

Authors:  Luigi Racioppi; Anthony R Means
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

3.  Inhibition of CaMKK2 reverses age-associated decline in bone mass.

Authors:  Zachary J Pritchard; Rachel L Cary; Chang Yang; Deborah V Novack; Michael J Voor; Uma Sankar
Journal:  Bone       Date:  2015-02-25       Impact factor: 4.398

4.  A cell-intrinsic role for CaMKK2 in granulocyte lineage commitment and differentiation.

Authors:  Ellen C Teng; Luigi Racioppi; Anthony R Means
Journal:  J Leukoc Biol       Date:  2011-08-04       Impact factor: 4.962

5.  Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages.

Authors:  Xianghong Zhang; David Wheeler; Ying Tang; Lanping Guo; Richard A Shapiro; Thomas J Ribar; Anthony R Means; Timothy R Billiar; Derek C Angus; Matthew R Rosengart
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells.

Authors:  Lance R Todd; Matthew N Damin; Rohini Gomathinayagam; Sarah R Horn; Anthony R Means; Uma Sankar
Journal:  Mol Biol Cell       Date:  2010-02-10       Impact factor: 4.138

Review 7.  Variability in the immune system: of vaccine responses and immune states.

Authors:  Shai S Shen-Orr; David Furman
Journal:  Curr Opin Immunol       Date:  2013-08-13       Impact factor: 7.486

8.  Why is an energy metabolic defect the common outcome in BMFS?

Authors:  Paolo Degan; Silvia Ravera; Enrico Cappelli
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

9.  BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV.

Authors:  Manabu Kokubo; Masahiro Nishio; Thomas J Ribar; Kristin A Anderson; Anne E West; Anthony R Means
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

10.  Repression of Ca2+/calmodulin-dependent protein kinase IV signaling accelerates retinoic acid-induced differentiation of human neuroblastoma cells.

Authors:  David M Feliciano; Arthur M Edelman
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.